These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 20685672)

  • 1. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism.
    Bellanné-Chantelot C; Saint-Martin C; Ribeiro MJ; Vaury C; Verkarre V; Arnoux JB; Valayannopoulos V; Gobrecht S; Sempoux C; Rahier J; Fournet JC; Jaubert F; Aigrain Y; Nihoul-Fékété C; de Lonlay P
    J Med Genet; 2010 Nov; 47(11):752-9. PubMed ID: 20685672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KATP channel mutations in congenital hyperinsulinism.
    Saint-Martin C; Arnoux JB; de Lonlay P; Bellanné-Chantelot C
    Semin Pediatr Surg; 2011 Feb; 20(1):18-22. PubMed ID: 21185999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism.
    Park SE; Flanagan SE; Hussain K; Ellard S; Shin CH; Yang SW
    Eur J Endocrinol; 2011 Jun; 164(6):919-26. PubMed ID: 21422196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism.
    Kapoor RR; Flanagan SE; Arya VB; Shield JP; Ellard S; Hussain K
    Eur J Endocrinol; 2013 Apr; 168(4):557-64. PubMed ID: 23345197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Congenital hyperinsulinism in newborn and infant].
    Giurgea I; Ribeiro MJ; Boddaert N; Touati G; Robert JJ; Saudubray JM; Jaubert F; Bellanné-Chantelot C; Brunelle F; Nihoul-Fékété C; de Lonlay P
    Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial ABCC8 gene deletion mutations causing diazoxide-unresponsive hyperinsulinaemic hypoglycaemia.
    Flanagan S; Damhuis A; Banerjee I; Rokicki D; Jefferies C; Kapoor R; Hussain K; Ellard S
    Pediatr Diabetes; 2012 May; 13(3):285-9. PubMed ID: 21978130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1.
    Macmullen CM; Zhou Q; Snider KE; Tewson PH; Becker SA; Aziz AR; Ganguly A; Shyng SL; Stanley CA
    Diabetes; 2011 Jun; 60(6):1797-804. PubMed ID: 21536946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia.
    Flanagan SE; Kapoor RR; Banerjee I; Hall C; Smith VV; Hussain K; Ellard S
    Clin Genet; 2011 Jun; 79(6):582-7. PubMed ID: 20573158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy.
    Sandal T; Laborie LB; Brusgaard K; Eide SA; Christesen HB; Søvik O; Njølstad PR; Molven A
    Clin Genet; 2009 May; 75(5):440-8. PubMed ID: 19475716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: clinical and functional characterization of two novel ABCC8 mutations.
    Faletra F; Snider K; Shyng SL; Bruno I; Athanasakis E; Gasparini P; Dionisi-Vici C; Ventura A; Zhou Q; Stanley CA; Burlina A
    Gene; 2013 Mar; 516(1):122-5. PubMed ID: 23266803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
    Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
    Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histological heterogeneity of congenital hyperinsulinism due to paternally inherited heterozygous ABCC8/KCNJ11 mutations.
    Arya VB; Guemes M; Nessa A; Alam S; Shah P; Gilbert C; Senniappan S; Flanagan SE; Ellard S; Hussain K
    Eur J Endocrinol; 2014 Dec; 171(6):685-95. PubMed ID: 25201519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.
    Pinney SE; MacMullen C; Becker S; Lin YW; Hanna C; Thornton P; Ganguly A; Shyng SL; Stanley CA
    J Clin Invest; 2008 Aug; 118(8):2877-86. PubMed ID: 18596924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures.
    Darendeliler F; Fournet JC; Baş F; Junien C; Gross MS; Bundak R; Saka N; Günöz H
    J Pediatr Endocrinol Metab; 2002; 15(7):993-1000. PubMed ID: 12199344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell.
    Oçal G; Flanagan SE; Hacihamdioğlu B; Berberoğlu M; Siklar Z; Ellard S; Savas Erdeve S; Okulu E; Akin IM; Atasay B; Arsan S; Yağmurlu A
    J Pediatr Endocrinol Metab; 2011; 24(11-12):1019-23. PubMed ID: 22308858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism.
    Banerjee I; Skae M; Flanagan SE; Rigby L; Patel L; Didi M; Blair J; Ehtisham S; Ellard S; Cosgrove KE; Dunne MJ; Clayton PE
    Eur J Endocrinol; 2011 May; 164(5):733-40. PubMed ID: 21378087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prematurity, macrosomia, hyperinsulinaemic hypoglycaemia and a dominant ABCC8 gene mutation.
    Khoriati D; Arya VB; Flanagan SE; Ellard S; Hussain K
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23563683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ABCC8 gene mutation and mosaic uniparental isodisomy resulting in atypical diffuse congenital hyperinsulinism.
    Hussain K; Flanagan SE; Smith VV; Ashworth M; Day M; Pierro A; Ellard S
    Diabetes; 2008 Jan; 57(1):259-63. PubMed ID: 17942822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic basis of congenital hyperinsulinism.
    James C; Kapoor RR; Ismail D; Hussain K
    J Med Genet; 2009 May; 46(5):289-99. PubMed ID: 19254908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex ABCC8 DNA variations in congenital hyperinsulinism: lessons from functional studies.
    Muzyamba M; Farzaneh T; Behe P; Thomas A; Christesen HB; Brusgaard K; Hussain K; Tinker A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):115-24. PubMed ID: 17466004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.